In this issue:
2017 revisions of the McDonald criteria
Clemastine fumarate as a remyelinating therapy for MS
Prediction of a MS diagnosis in CIS patients using 2016 MAGNIMS vs 2010 McDonald criteria
Increased prevalence and female ratio of MS over 15 years in northern Japan
Contribution of dietary intake to relapse rate in early paediatric MS
Integration of clinical and imaging measures to identify PPMS patients at risk of disease progression
Prognostic value of OCBs in a cohort of Sardinian MS patients
Attitudes and use of marijuana in youth with MS
Efficacy outcomes in vitamin D supplement users in the FREEDOMS trials
Influence of month of birth on the risk of developing MS
Please login below to download this issue (PDF)